We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Author Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis.
- Authors
Cui, Yuying; Guo, Yingxue
- Abstract
The sentence "studies used bevacizumab containing regimen as an intervention group and cetuximab-containing regimen as a control group;" is removed and "studies that compared bevacizumab containing regimens and cetuximab-containing regimens" is included. In the discussion section, the sentence "The subgroup analysis of RCTs did not show significant differences in OS between the bevacizumab and cetuximab-containing regimens." is included. We found a difference in PFS between bevacizumab-containing regimens and cetuximab-containing regimens in the subgroup analysis of RCTs (HR 0.91, 95% CI 0.83-1.00, P = 0.05, Fig.
- Subjects
COLORECTAL cancer; BEVACIZUMAB; CETUXIMAB; CANCER treatment
- Publication
International Journal of Clinical Pharmacy, 2023, Vol 45, Issue 4, p1022
- ISSN
2210-7703
- Publication type
Correction Notice
- DOI
10.1007/s11096-023-01598-6